Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Insmed (INSM) Shares Outstanding (2016 - 2026)

Insmed's Shares Outstanding history spans 17 years, with the latest figure at $216.5 million for Q1 2026.

  • Quarterly Shares Outstanding rose 19.03% to $216.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $216.5 million through Mar 2026, up 19.03% year-over-year, with the annual reading at $214.3 million for FY2025, 19.44% up from the prior year.
  • Shares Outstanding came in at $216.5 million for Q1 2026, up from $214.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $216.5 million in Q1 2026 to a low of $119.3 million in Q1 2022.
  • The 5-year median for Shares Outstanding is $148.6 million (2024), against an average of $163.3 million.
  • Year-over-year, Shares Outstanding increased 2.85% in 2022 and then grew 26.67% in 2025.
  • Insmed's Shares Outstanding stood at $135.7 million in 2022, then rose by 9.08% to $148.0 million in 2023, then rose by 21.22% to $179.4 million in 2024, then grew by 19.44% to $214.3 million in 2025, then grew by 1.06% to $216.5 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Shares Outstanding are $216.5 million (Q1 2026), $214.3 million (Q4 2025), and $212.6 million (Q3 2025).